Diagnostics Industry

Found 1,432 articles

• 

  A New Wave of Early Cancer Diagnostics is On Its Way

  7/19/2018

  Recent studies in early diagnostics underline just how much focus medical technology companies are making on developing different modalities for very early cancer diagnosis. Here are just some recent examples.

• Researchers Discover Key Link to Understanding Sleep Disorders

  7/19/2018

  Researchers have discovered a key link to potentially understanding sleep disorders in children, according to a study just published in the journal PLOS One.

• EKF POC HbA1c analyzer demonstrates excellent performance in international evaluation study

  7/19/2018

  Quo-Lab meets strict international quality targets – confirming it fit for purpose for diabetes testing.

• Owlstone Medical Appoints Five Leading Experts to Scientific Advisory Board

  7/19/2018

  Additions form a key strategic resource to advise on Breath Biopsy platform, product, and study development.

• UK Border Force Deploys Agilent Resolve Handheld Raman Systems for Hazardous Material Detection

  7/19/2018

  Agilent Technologies Inc. announced that UK Border Force is now using Resolve

• Mesa Biotech to Showcase New Molecular POC Testing Platform at the 2018 AACC Scientific Meeting

  7/18/2018

  Mesa Biotech Inc. announced it will showcase its novel Accula™ Flu A/Flu B test at the 70th Annual American Association of Clinical Chemistry Scientific Meeting & Clinical Lab Expo (AACC).

• Fujifilm Presents Innovative Imaging Solutions And Educational Opportunities At AHRA 2018 Annual Meeting

  7/18/2018

  FUJIFILM Medical Systems U.S.A., Inc. announced that it will offer educational opportunities and exhibit its latest innovations in digital radiography (DR), women's health and pediatric imaging portfolio at the Association for Medical Imaging Management (AHRA) 2018 Annual Meeting and Exposition.

• Lantheus Holdings to Host Second Quarter 2018 Earnings Conference Call on August 1, 2018 at 4:30 p.m. Eastern Time

  7/18/2018

  Lantheus Holdings, Inc. announced that it will host a conference call at 4:30 p.m. ET on Wednesday, August 1, 2018, to discuss its financial and operating results for the second quarter of 2018.

• EVIO Inc. Joins Prestigious Line-Up of Cannabis Business Exhibitors at NCIA's 5th Annual Cannabis Business Summit & Expo

  7/18/2018

  EVIO Inc. announced that it will be exhibiting Booth #1113 at the National Cannabis Industry Association's 5th Annual Cannabis Business Summit & Expo coming to San Jose, CA July 25-27, 2018.

• Alzheimer’s Therapeutics Research Leader Dr. Roy Twyman Joins NeuroVision Imaging Board

  7/18/2018

  Twyman Served as Senior Vice President at Janssen Pharmaceutical Research & Development, Overseeing Alzheimer’s Disease Therapeutics.

• QIAGEN N.V. to Report Second Quarter and First Half of 2018 Results

  7/17/2018

  QIAGEN N.V. plans as previously announced to release its report on results for the second quarter 2018 on Tuesday, July 31 shortly after 22:00 Central European Time (CET) / 16:00 Eastern Daylight Time (EDT).

• Co-Diagnostics Completes Submission of CE Mark Registration for Tuberculosis Screening Test

  7/17/2018

  ​Company’s Logix Smart™ MTB Test to be available for purchase with CE mark in August 2018

• Quidel to Hold Second Quarter 2018 Financial Results Conference Call on August 7, 2018

  7/17/2018

  Quidel Corporation will report second quarter 2018 financial results after market close on Tuesday, August 7, 2018.

• NanoView Biosciences Appoints Jerry Williamson as Chief Executive Officer

  7/17/2018

  Company prepares for commercial launch of its innovative products for detection and characterization of Exosomes

• Saladax Submits for FDA Review a Rapid Blood Test for Levels of Risperidone

  7/17/2018

  Saladax Biomedical Inc., a diagnostics company providing kits to test drug blood levels for adherence and personalized dose management, on July 3 submitted a De Novo classification request to the U.S. Food and Drug Administration (FDA) for the MyCare Psychiatry™ Total Risperidone Assay Kit.

• bioAffinity Technologies Opens Test Validation Trial of CyPath® Lung

  7/17/2018

  bioAffinity Technologies announced it has commenced its test validation trial for CyPath® Lung, an advanced flow cytometry test for the early detection of lung cancer. 

• Bio-Rad to Report Second-Quarter 2018 Financial Results Tuesday, August 7, 2018

  7/16/2018

  Bio-Rad Laboratories, Inc. will report financial results for the second quarter 2018 on Tuesday, August 7, 2018, following the close of the market.

• Diassess Receives $21.9 Million in Government Funding

  7/16/2018

  Funding Enables Diassess to Accelerate Development of Consumer-Focused Flu Diagnostic Technology

• Bardy Diagnostics™ Announces Additional Growth Capital Funding

  7/16/2018

  Bardy Diagnostics, Inc. announced it has raised additional growth capital from its existing equity investors, including SV Health Investors ("SVHI"), Health Enterprise Partners, and Ascension Ventures.

• Agilent Technologies Completes Acquisition of ULTRA Scientific Assets

  7/16/2018

  Agilent Technologies Inc. announced that it has completed the acquisition of the business assets of ULTRA Scientific, Inc., a leading provider of chemical standards and certified reference materials.